Form 4: ProMIS Neurosciences Executive Receives Stock Grant
Insider Transaction (Form 4)
Ivana Rubino, Chief Commercial Officer of ProMIS Neurosciences Inc., received 80,000 shares of common stock on October 5, 2026.
Summary
- Grant/award: acquired 80,000 Option (right to buy) on October 5, 2026; holds 80,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ivana Rubino — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Grant/award | Option (right to buy) | 80,000 | — | — | 80,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Grant/award (80,000 shares) |
Keywords
insider transaction, Form 4, PMN, ProMIS Neurosciences Inc., neutral, Ivana Rubino
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.